• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于诺达病毒衣壳纳米颗粒展示的M2e的潜在甲型流感病毒重组疫苗。

Potential recombinant vaccine against influenza A virus based on M2e displayed on nodaviral capsid nanoparticles.

作者信息

Yong Chean Yeah, Yeap Swee Keong, Ho Kok Lian, Omar Abdul Rahman, Tan Wen Siang

机构信息

Department of Microbiology, Faculty of Biotechnology and Biomolecular Sciences, Universiti Putra Malaysia, Selangor, Malaysia.

Institute of Bioscience, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, Selangor, Malaysia.

出版信息

Int J Nanomedicine. 2015 Apr 2;10:2751-63. doi: 10.2147/IJN.S77405. eCollection 2015.

DOI:10.2147/IJN.S77405
PMID:25897220
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4396508/
Abstract

Influenza A virus poses a major threat to human health, causing outbreaks from time to time. Currently available vaccines employ inactivated viruses of different strains to provide protection against influenza virus infection. However, high mutation rates of influenza virus hemagglutinin (H) and neuraminidase (N) glycoproteins give rise to vaccine escape mutants. Thus, an effective vaccine providing protection against all strains of influenza virus would be a valuable asset. The ectodomain of matrix 2 protein (M2e) was found to be highly conserved despite mutations of the H and N glycoproteins. Hence, one to five copies of M2e were fused to the carboxyl-terminal end of the recombinant nodavirus capsid protein derived from Macrobrachium rosenbergii. The chimeric proteins harboring up to five copies of M2e formed nanosized virus-like particles approximately 30 nm in diameter, which could be purified easily by immobilized metal affinity chromatography. BALB/c mice immunized subcutaneously with these chimeric proteins developed antibodies specifically against M2e, and the titer was proportional to the copy numbers of M2e displayed on the nodavirus capsid nanoparticles. The fusion proteins also induced a type 1 T helper immune response. Collectively, M2e displayed on the nodavirus capsid nanoparticles could provide an alternative solution to a possible influenza pandemic in the future.

摘要

甲型流感病毒对人类健康构成重大威胁,不时引发疫情。目前可用的疫苗采用不同毒株的灭活病毒来预防流感病毒感染。然而,流感病毒血凝素(H)和神经氨酸酶(N)糖蛋白的高突变率会产生疫苗逃逸突变体。因此,一种能预防所有流感病毒毒株的有效疫苗将是一项宝贵资产。尽管H和N糖蛋白发生了突变,但基质2蛋白(M2e)的胞外域被发现高度保守。因此,将一至五个M2e拷贝融合到源自罗氏沼虾的重组诺达病毒衣壳蛋白的羧基末端。携带多达五个M2e拷贝的嵌合蛋白形成了直径约30纳米的纳米级病毒样颗粒,可通过固定化金属亲和色谱轻松纯化。用这些嵌合蛋白皮下免疫的BALB/c小鼠产生了针对M2e的特异性抗体,且滴度与诺达病毒衣壳纳米颗粒上展示的M2e拷贝数成正比。融合蛋白还诱导了1型辅助性T细胞免疫反应。总体而言,展示在诺达病毒衣壳纳米颗粒上的M2e可为未来可能的流感大流行提供一种替代解决方案。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7986/4396508/cdcd6d8c1fe2/ijn-10-2751Fig7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7986/4396508/726ac03992cc/ijn-10-2751Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7986/4396508/b6dabe37d266/ijn-10-2751Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7986/4396508/806eb453e5a3/ijn-10-2751Fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7986/4396508/8a6ef035e200/ijn-10-2751Fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7986/4396508/e6c28214aeeb/ijn-10-2751Fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7986/4396508/9f07d5d11bbf/ijn-10-2751Fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7986/4396508/cdcd6d8c1fe2/ijn-10-2751Fig7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7986/4396508/726ac03992cc/ijn-10-2751Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7986/4396508/b6dabe37d266/ijn-10-2751Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7986/4396508/806eb453e5a3/ijn-10-2751Fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7986/4396508/8a6ef035e200/ijn-10-2751Fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7986/4396508/e6c28214aeeb/ijn-10-2751Fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7986/4396508/9f07d5d11bbf/ijn-10-2751Fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7986/4396508/cdcd6d8c1fe2/ijn-10-2751Fig7.jpg

相似文献

1
Potential recombinant vaccine against influenza A virus based on M2e displayed on nodaviral capsid nanoparticles.基于诺达病毒衣壳纳米颗粒展示的M2e的潜在甲型流感病毒重组疫苗。
Int J Nanomedicine. 2015 Apr 2;10:2751-63. doi: 10.2147/IJN.S77405. eCollection 2015.
2
Engineering of the PapMV vaccine platform with a shortened M2e peptide leads to an effective one dose influenza vaccine.采用缩短的M2e肽对PapMV疫苗平台进行工程改造,可制成有效的单剂量流感疫苗。
Vaccine. 2015 Dec 16;33(51):7245-7253. doi: 10.1016/j.vaccine.2015.10.123. Epub 2015 Nov 6.
3
Protection against multiple influenza A virus strains induced by candidate recombinant vaccine based on heterologous M2e peptides linked to flagellin.基于与鞭毛蛋白连接的异源M2e肽的候选重组疫苗诱导的对多种甲型流感病毒株的保护作用。
PLoS One. 2015 Mar 23;10(3):e0119520. doi: 10.1371/journal.pone.0119520. eCollection 2015.
4
Complete protection against a H5N2 avian influenza virus by a DNA vaccine expressing a fusion protein of H1N1 HA and M2e.通过表达 H1N1 血凝素 (HA) 和 M2e 融合蛋白的 DNA 疫苗实现对 H5N2 禽流感病毒的完全保护。
Vaccine. 2011 Jul 26;29(33):5481-7. doi: 10.1016/j.vaccine.2011.05.062. Epub 2011 Jun 12.
5
Potent immunogenicity and efficacy of a universal influenza vaccine candidate comprising a recombinant fusion protein linking influenza M2e to the TLR5 ligand flagellin.一种包含将流感病毒M2e与Toll样受体5(TLR5)配体鞭毛蛋白连接起来的重组融合蛋白的通用流感疫苗候选物具有强大的免疫原性和效力。
Vaccine. 2008 Jan 10;26(2):201-14. doi: 10.1016/j.vaccine.2007.10.062. Epub 2007 Nov 20.
6
Development of a candidate influenza vaccine based on virus-like particles displaying influenza M2e peptide into the immunodominant region of hepatitis B core antigen: Broad protective efficacy of particles carrying four copies of M2e.基于将流感M2e肽展示到乙型肝炎核心抗原免疫显性区域的病毒样颗粒开发候选流感疫苗:携带四个拷贝M2e的颗粒具有广泛的保护效力。
Vaccine. 2015 Jun 26;33(29):3398-406. doi: 10.1016/j.vaccine.2015.04.073. Epub 2015 May 11.
7
Highly conserved M2e and hemagglutinin epitope-based recombinant proteins induce protection against influenza virus infection.基于高度保守的 M2e 和血凝素表位的重组蛋白诱导对流感病毒感染的保护。
Microbes Infect. 2017 Dec;19(12):641-647. doi: 10.1016/j.micinf.2017.08.010. Epub 2017 Sep 10.
8
Protection against influenza A virus by vaccination with a recombinant fusion protein linking influenza M2e to human serum albumin (HSA).通过接种将流感病毒M2e与人血清白蛋白(HSA)连接的重组融合蛋白来预防甲型流感病毒。
J Virol Methods. 2016 Feb;228:84-90. doi: 10.1016/j.jviromet.2015.11.014. Epub 2015 Nov 23.
9
[Immunogenicity of recombinant proteins including ectodomain of M2 influenza virus A].[包括甲型流感病毒M2外膜域在内的重组蛋白的免疫原性]
Vopr Virusol. 2013 May-Jun;58(3):21-5.
10
In contrast to conventional inactivated influenza vaccines, 4xM2e.HSP70c fusion protein fully protected mice against lethal dose of H1, H3 and H9 influenza A isolates circulating in Iran.与传统的灭活流感疫苗相比,4xM2e.HSP70c 融合蛋白能完全保护小鼠免受在伊朗流行的 H1、H3 和 H9 流感 A 分离株的致死剂量的感染。
Virology. 2012 Aug 15;430(1):63-72. doi: 10.1016/j.virol.2012.04.015. Epub 2012 May 16.

引用本文的文献

1
Multifaceted virus-like particles: Navigating towards broadly effective influenza A virus vaccines.多面病毒样颗粒:迈向广谱有效的甲型流感病毒疫苗
Curr Res Microb Sci. 2024 Nov 15;8:100317. doi: 10.1016/j.crmicr.2024.100317. eCollection 2025.
2
Virus-like Particles of Nodavirus Displaying the Receptor Binding Domain of SARS-CoV-2 Spike Protein: A Potential VLP-Based COVID-19 Vaccine.展示 SARS-CoV-2 刺突蛋白受体结合域的类病毒颗粒:一种基于 VLP 的潜在 COVID-19 疫苗。
Int J Mol Sci. 2023 Feb 23;24(5):4398. doi: 10.3390/ijms24054398.
3
Development of virus-like particles-based vaccines against coronaviruses.

本文引用的文献

1
M2e-displaying virus-like particles with associated RNA promote T helper 1 type adaptive immunity against influenza A.展示相关 RNA 的 M2e 表位病毒样颗粒促进了针对甲型流感的 T 辅助 1 型适应性免疫。
PLoS One. 2013;8(3):e59081. doi: 10.1371/journal.pone.0059081. Epub 2013 Mar 18.
2
Enhanced Influenza VLP vaccines comprising matrix-2 ectodomain and nucleoprotein epitopes protects mice from lethal challenge.包含基质蛋白 2 胞外域和核蛋白表位的增强型流感病毒样颗粒疫苗可保护小鼠免受致死性攻击。
Antiviral Res. 2013 Apr;98(1):4-11. doi: 10.1016/j.antiviral.2013.01.010. Epub 2013 Feb 14.
3
Immunization with M2e-displaying T7 bacteriophage nanoparticles protects against influenza A virus challenge.
基于病毒样颗粒的冠状病毒疫苗的研制。
Biotechnol Prog. 2022 Nov;38(6):e3292. doi: 10.1002/btpr.3292. Epub 2022 Aug 19.
4
Investigation of Avian Influenza H5N6 Virus-like Particles as a Broad-Spectrum Vaccine Candidate against H5Nx Viruses.调查 H5N6 病毒样颗粒作为针对 H5Nx 病毒的广谱疫苗候选物。
Viruses. 2022 Apr 28;14(5):925. doi: 10.3390/v14050925.
5
Immunological Analysis of Nodavirus Capsid Displaying the Domain III of Japanese Encephalitis Virus Envelope Protein.展示日本脑炎病毒包膜蛋白结构域III的诺达病毒衣壳的免疫学分析
Pharmaceutics. 2021 Nov 1;13(11):1826. doi: 10.3390/pharmaceutics13111826.
6
Regulation of Proteolytic Activity to Improve the Recovery of Nodavirus Capsid Protein.调控蛋白水解活性以提高诺达病毒衣壳蛋白的回收率。
Int J Mol Sci. 2021 Aug 13;22(16):8725. doi: 10.3390/ijms22168725.
7
Chimeric virus-like particles (VLPs) designed from shrimp nodavirus (MrNV) capsid protein specifically target EGFR-positive human colorectal cancer cells.嵌合病毒样颗粒(VLPs)由虾诺达病毒(MrNV)衣壳蛋白设计而成,可特异性靶向 EGFR 阳性的人结直肠癌细胞。
Sci Rep. 2021 Aug 16;11(1):16579. doi: 10.1038/s41598-021-95891-x.
8
Chimeric Virus-Like Particles of Prawn Nodavirus Displaying Hepatitis B Virus Immunodominant Region: Biophysical Properties and Cytokine Response.虾诺达病毒嵌合病毒样颗粒展示乙肝病毒免疫优势区:生物物理特性和细胞因子反应。
Int J Mol Sci. 2021 Feb 15;22(4):1922. doi: 10.3390/ijms22041922.
9
Modular vaccine platform based on the norovirus-like particle.基于诺如病毒样颗粒的模块化疫苗平台。
J Nanobiotechnology. 2021 Jan 19;19(1):25. doi: 10.1186/s12951-021-00772-0.
10
Anti-Influenza Strategies Based on Nanoparticle Applications.基于纳米颗粒应用的抗流感策略
Pathogens. 2020 Dec 3;9(12):1020. doi: 10.3390/pathogens9121020.
M2e 展示 T7 噬菌体纳米颗粒免疫可预防甲型流感病毒挑战。
PLoS One. 2012;7(9):e45765. doi: 10.1371/journal.pone.0045765. Epub 2012 Sep 24.
4
Estimated global mortality associated with the first 12 months of 2009 pandemic influenza A H1N1 virus circulation: a modelling study.估算与 2009 年甲型 H1N1 流感病毒流行的头 12 个月相关的全球死亡人数:一项建模研究。
Lancet Infect Dis. 2012 Sep;12(9):687-95. doi: 10.1016/S1473-3099(12)70121-4. Epub 2012 Jun 26.
5
Evaluation of antigen specific recognition and cell mediated cytotoxicity by a modified lysispot assay in a rat colon carcinoma model.改良溶斑试验评估大鼠结肠癌模型中抗原特异性识别和细胞介导的细胞毒性。
J Exp Clin Cancer Res. 2012 Feb 1;31(1):9. doi: 10.1186/1756-9966-31-9.
6
Public health impact of including two lineages of influenza B in a quadrivalent seasonal influenza vaccine.包含两种乙型流感谱系的四价季节性流感疫苗对公共卫生的影响。
Vaccine. 2012 Mar 2;30(11):1993-8. doi: 10.1016/j.vaccine.2011.12.098. Epub 2012 Jan 5.
7
Virus-like particles of Macrobrachium rosenbergii nodavirus produced in bacteria.罗氏沼虾诺达病毒的细菌表达病毒样颗粒。
J Virol Methods. 2011 Jul;175(1):74-9. doi: 10.1016/j.jviromet.2011.04.021. Epub 2011 Apr 28.
8
Influenza virus assembly and budding.流感病毒的组装和出芽。
Virology. 2011 Mar 15;411(2):229-36. doi: 10.1016/j.virol.2010.12.003. Epub 2011 Jan 14.
9
Universal vaccine based on ectodomain of matrix protein 2 of influenza A: Fc receptors and alveolar macrophages mediate protection.基于甲型流感病毒基质蛋白 2 胞外域的通用疫苗:Fc 受体和肺泡巨噬细胞介导保护作用。
J Immunol. 2011 Jan 15;186(2):1022-31. doi: 10.4049/jimmunol.0902147. Epub 2010 Dec 17.
10
Single-dose mucosal immunization with a candidate universal influenza vaccine provides rapid protection from virulent H5N1, H3N2 and H1N1 viruses.单剂量黏膜免疫接种候选通用流感疫苗可快速预防高致病性 H5N1、H3N2 和 H1N1 病毒。
PLoS One. 2010 Oct 4;5(10):e13162. doi: 10.1371/journal.pone.0013162.